Evaluation of platelet count/spleen diameter ratio for detection of oesophageal varices in patients with cirrhosis of liver: a cross-sectional study


  • Ashok Mysore Lakshminarayana Department of General Medicine, Bangalore Medical College, Bengaluru, Karnataka, India
  • Shweta Mallikarjun Kumbar Department of General Medicine, Bangalore Medical College, Bengaluru, Karnataka, India
  • Manohara Melur Chandregowda Department of General Medicine, Bangalore Medical College, Bengaluru, Karnataka, India
  • Kiran Warrier Department of Pharmacology, Bangalore Medical College, Bengaluru, Karnataka, India




Oesophageal varices, Platelet count/splenic diameter ratio, Liver cirrhosis, Endoscopy


Background: Gastroesophageal varices due to portal hypertension in patients with liver cirrhosis is an important cause of morbidity and mortality. Gold standard investigation for varices is esophagogastroduodenoscopy and patients are advised to undergo regular follow up based on the risk stratification. But the invasive nature, risk of procedure-related complication and lack of accessibility and affordability makes it important to identify simpler methods to screen patients. Platelet count/spleen diameter (PSD) ratio has been validated as a marker for oesophageal varices (OV) in multiple studies but with varying results. The present study was conducted to evaluate the accuracy of PSD ratio in OV.

Methods: A cross-sectional study was conducted in patients diagnosed with liver cirrhosis. Clinical examination, relevant laboratory investigations, abdominal ultrasound and endoscopy were performed and data were recorded. PSD was calculated. Receiver-operator characteristics curves were plotted to determine cut-off values. Sensitivity, specificity, positive and negative predictive values were calculated.

Results: Total 100 patients were included in this study, out of which 25% of patients did not have varices on endoscopy. The mean PSD was for patients without varices 1242.82 (253.45) and 883.51 (582.38467) for patients with OV. The area-under-curve was 0.823, 95% CI=0.734-0.912, p value=0.000001. The cut-off value for PSD was calculated from the ROC analysis was 1077. The sensitivity, specificity, positive and negative predictive values were 76%, 88%, 95% and 55% respectively.

Conclusions: PSD ratio is not an efficient parameter for detection of varices in patients with liver cirrhosis. The current evidence does not support its role as a screening test for identification of patients with OV.

Author Biographies

Ashok Mysore Lakshminarayana, Department of General Medicine, Bangalore Medical College, Bengaluru, Karnataka, India


Shweta Mallikarjun Kumbar, Department of General Medicine, Bangalore Medical College, Bengaluru, Karnataka, India

Junior Resident

Manohara Melur Chandregowda, Department of General Medicine, Bangalore Medical College, Bengaluru, Karnataka, India

Junior resident


Merkel C, Marin R, Angeli P, Zanella P, Felder M, Bernardinello E, et al. A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis. Gastroenterology. 2004;127(2):476-84.

Jensen DM. Endoscopic screening for varices in cirrhosis: Findings, implications, and outcomes. Gastroenterology. 2002;122(6):1620-30.

Elalfy H, Elsherbiny W, Rahman AA, Elhammady D, Shaltout SW, Elsamanoudy AZ, et al. Diagnostic non-invasive model of large risky esophageal varices in cirrhotic hepatitis C virus patients. WJH. 2016;8(24):1028-37.

Moodley J, Lopez R, Carey W. Compliance with practice guidelines and risk of a first esophageal variceal hemorrhage in patients with cirrhosis. Clin Gastroenterol Hepatol. 2010;8(8):703-8.

Schepis F, Cammà C, Niceforo D, Magnano A, Pallio S, Cinquegrani M, et al. Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection? Hepatology. 2001;33(2):333-8.

Giannini EG, Botta F, Borro P, Dulbecco P, Testa E, Mansi C, et al. Application of the platelet count/spleen diameter ratio to rule out the presence of oesophageal varices in patients with cirrhosis: A validation study based on follow-up. Dig Liver Dis. 2005;37(10):779-85.

Thomopoulos K. Non-invasive prediction of esophageal varices: Is it possible? Saudi J Gastroenterol. 2011;17(1):1-3.

Witters P, Freson K, Verslype C, Peerlinck K, Hoylaerts M, Nevens F, et al. Review article: blood platelet number and function in chronic liver disease and cirrhosis. Aliment Pharmacol Ther. 2008;27(11):1017-29.

Chawla S, Katz A, Attar BM, Gupta A, Sandhu DS, Agarwal R. Platelet count/spleen diameter ratio to predict the presence of esophageal varices in patients with cirrhosis: a systematic review. Eur J Gastroenterol Hepatol. 2012;24(4):431-6.

Stefanescu H. Non-invasive assessment of portal hypertension in cirrhosis: liver stiffness and beyond. World J Gastroenterol. 2014;20(45):16811-9.

Lebrec D. Life, death, and varices. Gut. 2001;49(5):607-8.

Sepanlou SG, Safiri S, Bisignano C, Ikuta KS, Merat S, Saberifiroozi M, et al. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5(3):245-66.

Mangone M, Moretti A, Alivernini F, Papi C, Orefice R, Dezi A, et al. Platelet count/spleen diameter ratio for non-invasive diagnosis of oesophageal varices: is it useful in compensated cirrhosis? Dig Liver Dis. 2012;44(6):504-7.

Chen R, Deng H, Ding X, Xie C, Wang W, Shen Q. Platelet count to spleen diameter ratio for the diagnosis of gastroesophageal varices in liver cirrhosis: a systematic review and meta-analysis. Gastroenterol Res Pract.2017;2017:1-16.






Original Research Articles